Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Total Debt (2016 - 2025)

Historic Total Debt for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $21.6 billion.

  • Sanofi's Total Debt rose 2657.7% to $21.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $21.6 billion, marking a year-over-year increase of 2657.7%. This contributed to the annual value of $21.0 billion for FY2025, which is 2131.49% up from last year.
  • Sanofi's Total Debt amounted to $21.6 billion in Q4 2025, which was up 2657.7% from $23.2 billion recorded in Q2 2025.
  • In the past 5 years, Sanofi's Total Debt registered a high of $24.3 billion during Q2 2021, and its lowest value of $17.1 billion during Q4 2024.
  • Over the past 5 years, Sanofi's median Total Debt value was $21.1 billion (recorded in 2025), while the average stood at $21.1 billion.
  • Its Total Debt has fluctuated over the past 5 years, first crashed by 1647.04% in 2022, then soared by 2657.7% in 2025.
  • Sanofi's Total Debt (Quarter) stood at $23.2 billion in 2021, then decreased by 16.42% to $19.4 billion in 2022, then fell by 9.17% to $17.6 billion in 2023, then fell by 3.06% to $17.1 billion in 2024, then rose by 26.58% to $21.6 billion in 2025.
  • Its Total Debt stands at $21.6 billion for Q4 2025, versus $23.2 billion for Q2 2025 and $17.1 billion for Q4 2024.